Abstract
Pediatric Non-Hodgkin Lymphomas (NHL) are a diverse group of malignancies and as such treatment can vary based on the different biological characteristics of each malignancy. Significant advancements are being made in the treatment and outcomes of this group of malignancies. This is in large part due to novel targeted drug therapies that are being used in combination with traditional chemotherapy. Here, we discuss several new lines of therapy that are being developed or are in current use for pediatric patients with NHL.
| Original language | English |
|---|---|
| Article number | 28 |
| Journal | Pharmaceuticals |
| Volume | 9 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2016 |
Bibliographical note
Publisher Copyright:© 2016 by the authors; licensee MDPI, Basel, Switzerland.
Keywords
- Non-Hodgkin lymphoma
- Pediatric
- Targeted therapies
ASJC Scopus subject areas
- Molecular Medicine
- Pharmaceutical Science
- Drug Discovery
Fingerprint
Dive into the research topics of 'Targeted therapies for the treatment of pediatric non-hodgkin lymphomas: Present and future'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver